Background
Tuberculosis occurs in humans, cattle, wild animals and many other domesticated species. The Mycobacterium tuberculosis complex (MTC) comprises M. tuberculosis, M. bovis, M. africanum, M. canetti, M. pinnipedii, M. caprae, M. microti, M. mungi, Dassie bacillus, Oryx bacillus and the attenuated M. bovis Bacille-Calmette-Guerin (BCG) vaccine strain. With the exception of BCG, these species are pathogenic and can cause tuberculosis (TB) in mammalian hosts (Kabongo-Kayoka et al., 2015) .
Despite the fact that TB can be cured, this disease remains a worldwide public health threat due to the emergence of multi and extremely drug resistant strains and subsequent poor response to current antibiotics. One third of the world's population is infected with Mycobacterium tuberculosis (MTB) and is hence at risk of developing active TB. In the order of 9.6 million people every year develop TB and 1.5 million die from the disease. This includes 0.4 million TB deaths among HIV positive people (WHO, 2015) . From the 9.6 million, only 12% were HIV positive and it was also estimated that 480 000 cases of multidrug-resistant TB (MDR-TB) have occurred in 2014. This confirms that TB alone is still a major challenge.
There is currently no effective vaccine to protect against TB. In humans, control of the disease relies heavily on detecting infectious cases and treating them for at least six months with a combination of antibiotics. The course of antibiotics involves the administration of first-line anti-TB drugs, which are combinations of isoniazid (INH), rifampicin (RIF), pyrazinamide and ethambutol for 2 months to kill the rapidly growing bacteria. The treatment is continued in the next 4 months with a combination of INH and RIF because of their sterilizing activity to eliminate bacilli which are dormant in the macrophages, or slow growers (Rivers and Mancera, 2008) . Toxicity associated with these first-line drugs and the long duration of treatment has led to low patient compliance, giving rise to drug-resistant strains. Multidrug-resistant mycobacteria are resistant to INH and RIF whereas extremely drug-resistant mycobacteria are resistant to second-line drugs such as fluoroquinolones and to at least one injectable drug in addition to INH and RIF. Hence, there is a need to find new anti-tubercular agents with novel modes of actions (Chinsembu, 2016) .
It is most likely that the emergence of resistant Mycobacterium isolates will continue in the future, exhausting the current range of effective antibiotics available. Therefore, new classes of anti-TB agents are urgently needed, and research projects seeking for alternative therapeutics have been encouraged. Natural resources have been explored to develop new antibiotics.
Substances that can either inhibit the growth of pathogens or kill them while having little or no toxicity to host cells are considered good candidates for developing new antimicrobial drugs (Nguta et al., 2016) .
Medicinal plants are used in many parts of the world to treat different ailments including TBrelated symptoms such as chest complaints, respiratory ailments, fever and coughing (McGaw et al., 2008) . Relevant reviews of traditional medicinal use of plants in Africa are available (Hutchings et al., 1996; Kuete, 2010; Maroyi, 2013; Nguta et al., 2016; Stark et al., 2013; Van Wyk et al., 1997) .
South Africa possesses the richest temperate flora in the world, with an estimated 24 000 species and intraspecific taxa in 368 families-more than 10% of the world's vascular plant flora (Germishuizen and Meyer, 2003) . There is much potential for discovery of structurally interesting metabolites with activity against Mycobacterium species from these plants. The existence of a strong cultural reliance on traditional medicines within South African communities justifies the importance of studying their safety and efficacy (Fennell et al., 2004) .
In a study conducted on Indian medicinal plants, Gautam et al., (2007) reported that with many of the plant species examined, there was a strong positive correlation between antimycobacterial activity and ethnomedicinal use for TB and TB-related diseases. Although this provides support for investigating plants customarily used in other cultures to treat symptoms relating to TB, other plants tested for antimycobacterial activity using indicator organisms such as M. smegmatis and M. bovis BCG should also be investigated (McGaw et al., 2008) . Testing plant material not only against ATCC strains but against current isolates is crucial as these microorganisms are part of the changing environment harbouring emerging resistant strains.
The Anacardiaceae, cashew or Sumac is a tropical family that comprises flowering plant bearing fruits that are drupes and in some cases producing urushiol which is an irritant substance (Mabberley, 1997 (Pistacia lentiscus, Pistacia integrrima) . This family which belongs to the order of sapindales is represented by 77 genera and 600 species mostly distributed in tropical, subtropical, and temperate areas (Mabberley, 1997) . Very few plant species of the Anacardiaceae family have been investigated for antimycobacterial activity. One of the objectives of this study was to investigate in vitro antimycobacterial activities as well as cytotoxicity of selected plant species from the Anacardiaceae family. These plants were selected mainly based on a preliminary broad antimicrobial screening (Pauw and Eloff, 2014) .
A summary on ethnobotanical use of the selected plant species from the Anacardiaceae family is presented in Table 1 (Volpe et al., 2006) .
Materials and Methods

2.1Source of plant materials and extraction
Leaves of the 15 plant species were collected in November 2009 from the Lowveld National Botanical Gardens in Nelspruit, the University of Pretoria Botanical Gardens and the Pretoria National Botanical Garden, South Africa in terms of a signed material transfer agreement.
Leaves were kept in labelled bags with full identification and collection dates. Voucher specimens were kept in the Lowveld National Botanical Gardens (Nelspruit), HGWJ Acetone was used as the extracting solvent due to its ability to extract a wide range of compounds and low toxicity on different microorganisms (Eloff, 1998a) . The tube was vigorously shaken for 30 min on an orbital shaker, then centrifuged at 4000 × g for 10 min and the supernatant was filtered using Whatman No.1, 110mm diameter filter paper, before being transferred into pre-weighed glass containers (Eloff, 1998a) . The extraction was repeated thrice on the same plant material and the solvent was removed by evaporation under a stream of air in a fume hood at room temperature to produce the dried extract. Extracts were made up to a concentration of 10 mg/mL in acetone for use in relevant tests.
Insert table 1
Antimycobacterial activity
The antimycobacterial activity of the acetone crude extracts of leaf powder was determined by using bioautography and the two-fold serial microdilution method. The pathogenic and rapidly growing mycobacteria were test microorganisms used for antimycobacterial activity. 
Maintenance of cultures
Fresh cultures were used in the relevant assays. The pathogenic isolates of Mycobacterium spp.
were kept at room temperature on Lowenstein-Jensen (LJ) slants supplemented with glycerol or pyruvate in the case of the M. bovis BCG cultures and were used within a month. Prior to each assay, cultures were reactivated in liquid medium , Middlebrook 7H9, using MGIT 960 tubes which were incubated at 37°C in the BACTEC MGIT 960 instrument, in which they were automatically monitored each hour for fluorescence development for 42 days or until a positive signal developed. Bacterial suspensions from MGIT tubes were then subcultured on solid medium LJ slants with pyruvate for M. bovis and LJ slants with glycerol for M. tuberculosis.
Löwenstein Jensen tubes were then incubated in a walk-in incubator at 37 °C for 4 to 6 weeks.
A stained Ziehl Neelsen smear was made from the sediment of the MGIT tube and the slant of LJ
medium. Reference cultures of M. avium (ATCC 25291), M. bovis BCG and M. tuberculosis
H37Ra (ATCC 25177) were used as positive controls.
The rapidly growing Mycobacterium species were maintained on Middlebrook 7H10 Agar prepared according to the manufacturer instructions (Merck) and kept in a fridge at 4°C until used within a month. Mycobacterium aurum and M. fortuitum were revived using Middlebrook 7H9 broth with glycerol and tween and supplemented with OADC (Oleic acid Albumin Dextrose Catalase) whereas M. smegmatis was revived using MH broth (Merck). Bacterial suspensions were inoculated on MH agar plates for M. smegmatis and the rest on Middlebrook 7H9 Agar.
All agar plates were then incubated at 37 °C until colony growth was visible within 24 to72
hours depending on the growth rate of the specific mycobacterial species. The final density of 1
x 10 5 CFU/mL used was confirmed after spreading an inoculum of 100 μL of tenfold serial dilutions of the bacterial suspensions at McFarland No 1 onto Middlebrook 7H10 (M7H10) agar plates incubated at 37°C and counting colonies.
Minimum inhibitory concentration (MIC) determination
The MIC values were determined using the serial microplate method developed by Eloff ( supplemented with 10% OADC. These colonies were transferred into a sterile screw capped tube containing 3 ml of M7H9 broth and homogenized by placing the tube on a Vortex mixer for 5 minutes. After the larger particles had settled, the mycobacterial suspension was adjusted to
McFarland no.1 turbidity standard by adding more broth (Lall and Meyer, 1999) .
The assay was performed using sterile 96-well microplates with rounded bottoms. The sample to be tested (plant extract, drug, fraction) was prepared at a concentration of 10 mg/ml before serial dilution. One hundred µl of M7H9 broth or MH broth was added to all the wells then 100 µl of the sample to be tested were added in three adjacent column wells in the first row whereas other wells included standard drugs positive controls to assess bacterial growth, solvent control, broth to be inoculated and clean broth for sterility check. Two samples of crude extract and one standard drug were run per plate. A two fold serial dilution was carried out leaving 100 µl of different concentrations of diluted tested samples in each well starting with a concentration of 2.5 mg/ml in the first wells. Then 100 µl of the test bacterial suspension were added to all the wells except column 12 (negative control) containing pure broth to make sure that there was no contamination of the broth. Each dose was run in triplicate and the experiment repeated at least six times. The standard antibiotics (reference drugs) included ciprofloxacin, rifampicin, isoniazid and streptomycin starting with a concentration of 100µg/ml. The microplates were covered and sealed in plastic bags, placed in humid chambers to minimize the evaporation of the culture medium and incubated at 37°C for 24 hours (M. smegmatis), 48 hours (M. fortuitum) and 72 hours (M. aurum). For the pathogenic mycobacteria, microplates were incubated for a period of 7 to 15 days.
At the end of incubation, a volume of 40 µl of 0.2 mg/ml of iodonitrotetrazolium chloride (INT) was added to each well, plates were incubated for 30 minutes or longer at 37°C and the development of colour observed. A coloured red-purple formazan or pink color indicated the reduction of INT by metabolizing organisms whereas a yellow color or decrease in color indicated the inhibition of bacterial growth (Eloff, 1998b) . If the colour development was not strong enough for slow growing organisms, plates were incubated much longer and monitored.
The correlation assessing the relationship between the MIC values of the 7 mycobacterial species used (Table 3) the Rf values of antimycobacterial compounds separated on the thin layer chromatography plates (Hamburger and Cordell, 1987) .
In vitro cytotoxicity assay and selectivity index
The cytotoxicity of crude acetone extracts from plants with good MIC values and clear zones of inhibition on bioautography was determined using a tetrazolium-based colorimetric assay, 3-(4, 5-dimethylthiazol)-2, 5-diphenyl tetrazolium bromide (MTT assay) described by (Mosmann, 1983) and slightly modified by (McGaw et al., 2007) . 
Statistical analysis
All experiments were conducted in triplicate and values expressed as mean ± standard deviation.
For the MIC values, re-evaluation of the growth inhibition was conducted where a wide variation within the three experiments was noticed. The relationship between the different mycobacterial MIC values was calculated using the Pearson's correlation coefficient (r).
Results and Discussion
Acetone extract plant yield
The extraction yield of the plant species ranged from 0.8 to 18.8% (Table 2 ). The highest percentage was observed with Searsia magaliesmontana (18.8%) followed by Searsia undulata (12.5%) and Protorhus longifolia (8.3%). Heeria argentea had the lowest yield of 0.8%. The extraction yield and bioactivities of extracts using different extractants vary strongly (Kotzé and Eloff, 2002) , hence the choice of acetone in this study.
Insert table 2
Biological activity of extracts
Bioautography of extracts using two (M. aurum and M. fortuitum) out of the three rapidly growing mycobacteria led to strong, clear zones of inhibition. This also corresponded with low MIC values obtained ranging from 0.05 to 0.1 mg/ml.
Extracts with MIC values ≤ 0.1mg/mL were considered to have significant activity; moderate activity was between 0.1 and 0.625 mg /mL and weak or poor activity (resistant) with MICs >0.
625 mg /mL (Kuete, 2010) . All 15 plant extracts had good to moderate antimycobacterial activity against rapidly growing and pathogenic mycobacteria ranging from 0.05 to 0.590 mg/mL. Searsia undulata extracts had significant antimycobacterial activity with the lowest MIC value of 0.07 mg/mL for M. aurum and M. fortuitum followed by M. smegmatis with MIC of 0.09 mg/mL. Protorhus longifolia extracts also had significant antimycobacterial activity against all three non-tuberculous mycobacteria with MIC values of 0.11 mg/mL for both M.
aurum and M. fortuitum and 0.07 mg/mL for M. smegmatis. Searsia lancea, Sclerocarya birrea
and Harpehyllum caffrum had moderate activity of 0.420 mg/mL, 0.520 mg/mL and 0.590 mg/mL against M. aurum respectively whereas the same plant species had moderate activity with low MIC values of 0.21 and 0.11 mg/mL; 0.13 and 0.21 mg/mL and 0.21and 0.11 mg/mL against 
Insert table 3
The total activity value of an extract from a plant indicates which species could be the candidates for organic production of active extracts for use by communities because it takes into account not only the MIC of the extract but also the yield of the extract. By dividing the extraction yield in mg/g by the MIC in mg/ml the total activity is calculated in ml/g (Eloff, 2000) . This provides the volume in ml that the extract from 1 g of dry material can be diluted and still kills the pathogen. Searsia undulata had the lowest MIC values (significant activity) with the highest % yield and highest total activity of 5 357 mL/g on M. fortuitum and 2885 mL/g on MDR-TB followed by Protorhus longifolia showing the highest total activity of 3557 mL/g on M.
smegmatis and 2264 mL/g on MDR-TB. The results of total activity using rapidly growing mycobacteria are not shown due to limitation on number of tables. These two plants are the best candidates for further investigation due to their low cytotoxicity and more than 30
antimycobacterial compounds observed using bioautography. In addition, (Mosa et al., 2014) reported that Protorhus longifolia had antibacterial activity towards resistant clinical isolates of
Gram negative (Pseudomonas aeruginosa) and Gram positive (Staphylococcus aureus) whereas
Searsia undulata has been used to treat chest cold (Hutchings et al., 1996) . Specific antimicrobials targeting Gram negative and Gram positive bacteria are useful but this does not eliminate the need for broader spectrum antimicrobials. However, other plants with moderate activity are worthy of investigation as studies have shown that there is synergy among different compounds within an extract and once fractionated, different fractions/compounds might be more active than the crude extract (Awouafack et al., 2013) .
Bioautography and thin layer chromatography analysis
Although all selected plant species had significant to moderate activity against all Mycobacterium species tested, plants showing at least MIC below 0.1 mg/mL or close to 0.1 mg/mL for any of the mycobacteria tested were selected to be investigated by bioautography. extracts with SI values less than1 mean that the extracts are relatively less toxic to the bacteria and more toxic to the mammalian cells (Eloff, 2000) . Therefore, extracts with SI >1 may be relatively safer to use in vivo (not accounting for pharmacokinetic parameters) as they are less toxic to mammalian cells but more toxic to the pathogens. The selectivity indexes, especially of P. longifolia with SI = 12. 6 could be considered as very promising as a good therapeutic index for a remedy or drug should be ≥10 (Caamal-Fuentes et al., 2011) . It is also worth noting that efficacy "in vitro" might differ from efficacy 'in vivo" due to different parameters influencing pharmacodynamics and pharmacokinetic of drugs administered by different routes to humans and animals. In this study, Protorhus longifolia and Searsia undulata had the highest selectivity index against the three rapidly growing mycobacteria and pathogenic mycobacteria and the highest total activity. These rapidly growing species had the highest total activity of 5357 mL/g for S. undulata and 3557 mL/g for P. longifolia which indicates the volume to which the extract from 1 g can be diluted and still inhibit the growth of mycobacteria. It is also worth noting that the leaves of S. undulata are chewed by Khoi people to treat chest cold, indicating a low toxicity.
The mode of administration and interaction with other factors in" vivo" must be considered when assessing toxicity.
Insert Table 4 4. Conclusion
This is the first report on antimycobacterial activity of these tree species from the Anacardiaceae family in Africa. The bolded values represent the correlation between rapidly growing Mycobacteria and pathogenic Mycobacteria. 
